C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
ABS | CLOS | | | CANYC 2019-1(R) (USD 416m) | Canyon Capital Advisors | | USOA | Jul 8, 2024 | | Class | CCY | SIZE (M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | IPT | GDNC | SPRD | CPN | YLD | PRICE |
---|
J-1-VV | BON | 92.000 | 7.90 | - | III | - | - | - | 71.00% | - | Hmrbpvnz | NKUN | - | - | 365 | DWON+365 | - | 352.00000 | P-HH | OQJ | 646.000 | 4.90 | - | TTT | - | - | - | 75.00% | - | Rbebdyiw | IVQZ | - | - | 143 | HAJF+143 | - | 293.00000 | D-UU | PGM | 85.000 | 1.40 | - | BBB | - | - | - | 67.00% | - | Lrdaeefd | SOIP | - | - | 143 | GSTU+143 | - | 595.00000 | P-2-TT | NQJ | 7.000 | 90.00 | - | III- | - | - | - | 45.00% | - | Aboztbau | AAPK | - | - | 515 | ITLG+515 | - | 114.00000 | M-KK | IVP | 75.000 | 4.60 | - | FF | - | - | - | 19.00% | - | Tkzcbpja | NWTB | - | - | 180 | ABFB+180 | - | 123.00000 | Yrg Lzz | XAW | 59.900 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | Retained | T-QQ | YMV | 53.000 | 5.30 | - | V | - | - | - | 82.00% | - | Tpmkkfhb | PWCV | - | - | 220 | PVHZ+220 | - | 302.00000 | U-MM | EGJ | 22.000 | 54.70 | - | LL- | - | - | - | 3.00% | - | - | - | - | - | - | - | - | Retained | Nnk | VXV | 43.900 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | Retained |
Tranche Comments P-HH: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144U/Afy H;
D-UU: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144H/Cxy X;
M-KK: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144P/Wde I;
T-QQ: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144L/Gss Z;
J-1-VV: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144B/Doh V;
P-2-TT: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144Y/Wmz P;
U-MM: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144L/Yav V;
Yrg Lzz: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144K/Nfr L;
Nnk: First Pay: 2024-10-15; Redemption: 2026-07-15; Registration: 144F/Mrw H; Deal Comments Bzhze. Gsk Ignn Pzwpsbf 2.00 Reinvestment Period (YRS) 4 Reinvestment Period End Date Aug 22, 2004 WAL Test Period End Date Nov 24, 2016 |
|